Search clinical trials for: CT Perth

Total 10000 results

Context Therapeutics Inc.

Recruiting

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers (CT-202)

Colorectal Cancer | Urothelial Cancer | Triple Negative Breast Cancer (TNBC)

Australia
Novartis Pharmaceuticals

Recruiting

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Cardiovascular Disease and Lipoprotein(a)

United States, China, Spain, Canada, France, Romania, Switzerland, Greece, Italy, Germany, Australia, Austria, Norway, United Kingdom, Hong Kong, Bulgaria, Belgium, India, Slovenia, Denmark, Mexico, Taiwan, Israel, Poland, Brazil, Hungary, ... and more
Contineum Therapeutics

Recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Canada, Australia, United Kingdom, Serbia, Argentina, Israel, South Korea, Chile, New Zealand
BeOne Medicines

Recruiting

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

B Cell Lymphoma | Mantle Cell Lymphoma

United States, Japan, United Kingdom, Germany, China, Austria, New Zealand, Spain, Australia, Italy, Puerto Rico, France, Argentina, Brazil, Poland, South Korea, Turkey (Türkiye)
Lomond Therapeutics Holdings, Inc.

Recruiting

Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia

AML With Gene Mutations

United States, Australia, Taiwan, South Korea

Search clinical trials for: CT Perth

This is a preview